Adrogolide (hydrochloride)
Adrogolide hydrochloride (ABT-431 hydrochloride) is a chemically stable prodrug that can convert to the dopamine D1 receptor agonist A-86929. Adrogolide hydrochloride ameliorates the MPTP -induced Parkinson's Disease in marmoset model, reduces the dyskinesias tendency. Adrogolide hydrochloride reverses Risperidone (HY-11018) -induced cognitive deficits in monkey[1].
Product Specifications
CAS Number
166591-11-3
Product Name Alternative
ABT-431 (hydrochloride) ; DAS-431 (hydrochloride)
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/adrogolide-hydrochloride.html
Purity
99.57
Solubility
DMSO : 66.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCC1=CC2=C(CN[C@@]3(CCC4=CC(OC(C)=O)=C(C=C4[C@@]23[H])OC(C)=O)[H])S1.[H]Cl
Molecular Formula
C22H26ClNO4S
Molecular Weight
435.96
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature, keep dry and cool
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD18 (Leukocyte Function Associated Antigen, LFA-1 beta2) (FITC) discontinued
![CD13 Rabbit Monoclonal Antibody [KD Validation]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Recombinant Human Protein-arginine deiminase type-3 (PADI3)
Recombinant Human Protein-arginine deiminase type-3 (PADI3)